Natixis’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.29M | Sell |
17,885
-141,761
| -89% | -$50.5M | 0.02% | 391 |
|
|
2025
Q4 | $52.3M | Buy |
159,646
+138,863
| +668% | +$44M | 0.19% | 76 |
|
|
2025
Q3 | $5.86M | Buy |
20,783
+20,540
| +8,453% | +$5.96M | 0.03% | 404 |
|
|
2025
Q2 | $67.8K | Sell |
243
-31,439
| -99% | -$8.91M | ﹤0.01% | 861 |
|
|
2025
Q1 | $9.89M | Buy |
31,682
+19,704
| +165% | +$5.82M | 0.05% | 231 |
|
|
2024
Q4 | $3.12M | Sell |
11,978
-58,754
| -83% | -$17.4M | 0.02% | 402 |
|
|
2024
Q3 | $22.8M | Buy |
70,732
+63,652
| +899% | +$20.8M | 0.13% | 116 |
|
|
2024
Q2 | $2.21M | Sell |
7,080
-63,980
| -90% | -$18.8M | 0.01% | 391 |
|
|
2024
Q1 | $20.2M | Sell |
71,060
-195,935
| -73% | -$57.3M | 0.11% | 152 |
|
|
2023
Q4 | $76.9M | Buy |
266,995
+109,869
| +70% | +$29.9M | 0.56% | 31 |
|
|
2023
Q3 | $42.2M | Buy |
157,126
+34,303
| +28% | +$8.56M | 0.32% | 65 |
|
|
2023
Q2 | $27.3M | Sell |
122,823
-206,932
| -63% | -$48M | 0.22% | 100 |
|
|
2023
Q1 | $79.7M | Sell |
329,755
-185,754
| -36% | -$45.6M | 0.72% | 23 |
|
|
2022
Q4 | $135M | Buy |
515,509
+412,405
| +400% | +$111M | 0.76% | 29 |
|
|
2022
Q3 | $23.3M | Buy |
103,104
+25,599
| +33% | +$6.21M | 0.11% | 142 |
|
|
2022
Q2 | $18.9M | Sell |
77,505
-275,958
| -78% | -$67.6M | 0.07% | 188 |
|
|
2022
Q1 | $85.5M | Buy |
353,463
+121,856
| +53% | +$28M | 0.3% | 63 |
|
|
2021
Q4 | $52.1M | Buy |
231,607
+170,978
| +282% | +$36.1M | 0.18% | 101 |
|
|
2021
Q3 | $12.9M | Sell |
60,629
-99,802
| -62% | -$23M | 0.04% | 315 |
|
|
2021
Q2 | $39.1M | Buy |
160,431
+14,705
| +10% | +$3.62M | 0.17% | 119 |
|
|
2021
Q1 | $36.3M | Sell |
145,726
-32,535
| -18% | -$7.76M | 0.12% | 176 |
|
|
2020
Q4 | $41M | Buy |
+178,261
| New | +$41.1M | 0.15% | 143 |
|
|
2020
Q3 | – | Sell |
-161,524
| Closed | -$38.1M | – | 737 |
|
|
2020
Q2 | $38.1M | Sell |
161,524
-311,517
| -66% | -$71.1M | 0.3% | 71 |
|
|
2020
Q1 | $95.9M | Sell |
473,041
-191,224
| -29% | -$41.8M | 0.75% | 30 |
|
|
2019
Q4 | $160M | Sell |
664,265
-522,634
| -44% | -$115M | 0.99% | 11 |
|
|
2019
Q3 | $230M | Buy |
+1,186,899
| New | +$228M | 1.48% | 11 |
|
|
2019
Q2 | – | Sell |
-418,718
| Closed | -$78.6M | – | 733 |
|
|
2019
Q1 | $78.6M | Buy |
+418,718
| New | +$80M | 0.49% | 38 |
|
|
2018
Q3 | – | Sell |
-529,816
| Closed | -$97.8M | – | 786 |
|
|
2018
Q2 | $97.8M | Buy |
529,816
+510,281
| +2,612% | +$90.3M | 0.52% | 46 |
|
|
2018
Q1 | $3.33M | Sell |
19,535
-91,245
| -82% | -$16.7M | 0.02% | 431 |
|
|
2017
Q4 | $19.3M | Sell |
110,780
-12,778
| -10% | -$2.26M | 0.15% | 148 |
|
|
2017
Q3 | $23M | Buy |
+123,558
| New | +$21.9M | 0.21% | 118 |
|
|
2017
Q2 | – | Sell |
-332,277
| Closed | -$54.5M | – | 793 |
|
|
2017
Q1 | $54.5M | Buy |
332,277
+283,592
| +583% | +$47.1M | 0.68% | 40 |
|
|
2016
Q4 | $7.12M | Buy |
48,685
+28,579
| +142% | +$4.3M | 0.07% | 222 |
|
|
2016
Q3 | $3.35M | Sell |
20,106
-20,468
| -50% | -$3.46M | 0.04% | 232 |
|
|
2016
Q2 | $6.17M | Buy |
+40,574
| New | +$6.31M | 0.11% | 149 |
|
|
2016
Q1 | – | Sell |
-58,705
| Closed | -$9.53M | – | 305 |
|
|
2015
Q4 | $9.53M | Buy |
+58,705
| New | +$9.23M | 0.16% | 85 |
|
|
2015
Q3 | – | Sell |
-705,036
| Closed | -$108M | – | 310 |
|
|
2015
Q2 | $108M | Buy |
705,036
+490,821
| +229% | +$78.6M | 1.46% | 13 |
|
|
2015
Q1 | $34.2M | Buy |
+214,215
| New | +$33.7M | 0.47% | 39 |
|
|
2014
Q4 | – | Sell |
-295,503
| Closed | -$41.5M | – | 381 |
|
|
2014
Q3 | $41.5M | Buy |
295,503
+132,359
| +81% | +$17.3M | 0.64% | 26 |
|
|
2014
Q2 | $19.3M | Sell |
163,144
-63,844
| -28% | -$7.39M | 0.23% | 98 |
|
|
2014
Q1 | $28M | Buy |
226,988
+1,420
| +0.6% | +$172K | 0.36% | 72 |
|
|
2013
Q4 | $25.8M | Buy |
+225,568
| New | +$25.7M | 0.22% | 99 |
|
|
2013
Q3 | – | Sell |
-301,652
| Closed | -$29.8M | – | 497 |
|
|
2013
Q2 | $29.8M | Buy |
+301,652
| New | +$31.3M | 0.43% | 58 |
|
Other funds holding AMGN
VCM
VPM
Natixis's AMGN Position: Q1 2026 in Review
Natixis reduced its Amgen (AMGN) stake by 89% in Q1 2026, selling an estimated $50.5M and leaving 17,885 shares worth $6.29M. The position accounts for 0.02% of the portfolio, ranked #391.
Natixis first reported a position in AMGN in Q2 2013 and has held it in 43 quarters since. The position peaked at $230M in Q3 2019. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Natixis held 17,885 shares of Amgen worth $6.29M as of Q1 2026.
- Natixis sold 141,761 Amgen shares in Q1 2026, an estimated $50.5M.
- Amgen made up 0.02% of Natixis's portfolio in Q1 2026, its #391 holding.
- Natixis first reported a position in Amgen in Q2 2013 and has held it in 43 quarters since.
- Natixis's Amgen position peaked at $230M in Q3 2019.
- 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Natixis's 13F filing for Q1 2026, filed 14 May 2026.